Home » Topics » BioWorld Science

BioWorld Science
RSS

Safety and efficacy of once-weekly insulin icodec compared with once-daily glargine in phase II

Dec. 24, 2020

11C-PABA for dynamic PET to evaluate renal function: preclinical and first-in-human results

Dec. 24, 2020

CDI-45205 selected as lead compound for development against coronaviruses

Dec. 24, 2020

Enrollment ongoing in phase II study of LX-9211 in postherpetic neuralgia

Dec. 24, 2020

Acticor initiates phase II trial of glenzocimab to treat COVID-19 related ARDS

Dec. 23, 2020

BioCryst reports part 1 data from clinical trial of galidesivir in COVID-19

Dec. 23, 2020

FDA places clinical hold on uniQure's hemophilia B gene therapy program

Dec. 23, 2020

SOURCE trial of tezepelumab in severe asthma misses primary endpoint

Dec. 23, 2020

Phase III study of SPN-812 for adult ADHD meets primary endpoint

Dec. 23, 2020

FDA approves Kineret to treat deficiency of IL-1 receptor antagonist

Dec. 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026